Title: Epidemiology and outcomes of gastrointestinal mucosal melanomas: A national database
analysis
Version: 3 Date: 20 Feb 2022
Reviewer:  Fabio Melandro
Reviewer's report:
I read with great interest the paper of Shah et al. The authors  highlighted the treatment
strategies on very rare disease namely gastrointestinal mucosal melanomas analyzing  US
national database.
The study is interesting and innovative.
The Introduction is well written and has sufficient background information in particular in
epidemiology aspects.
Nevertheless, there is a lack of information In surgical procedure, extension of resection,
limphoadenectomy, surgical complications.
The same limited informations are evident in chemotherapy and radiotherapy schedules.
Please move the limitations of the study at the end of discussion paragraph.
The take home message in therapeutic approach in this field should be added in the conclusions.
Title: Epidemiology and outcomes of gastrointestinal mucosal melanomas: A national database
analysis
Version: 3 Date: 20 Feb 2022
Reviewer:  Fabio Melandro
Reviewer's report:
I read with great interest the paper of Shah et al. The authors  highlighted the treatment
strategies on very rare disease namely gastrointestinal mucosal melanomas analyzing  US
national database.
The study is interesting and innovative.
The Introduction is well written and has sufficient background information in particular in
epidemiology aspects.
Nevertheless, there is a lack of information In surgical procedure, extension of resection,
limphoadenectomy, surgical complications.
The same limited informations are evident in chemotherapy and radiotherapy schedules.
Please move the limitations of the study at the end of discussion paragraph.
The take home message in therapeutic approach in this field should be added in the conclusions.
Please review this paper.
user
Title: Epidemiology and outcomes of gastrointestinal mucosal melanomas: A national database
analysis
Version: 3 Date: 20 Feb 2022
Reviewer:  Fabio Melandro
Reviewer's report:
I read with great interest the paper of Shah et al. The authors  highlighted the treatment
strategies on very rare disease namely gastrointestinal mucosal melanomas analyzing  US
national database.
The study is interesting and innovative.
The Introduction is well written and has sufficient background information in particular in
epidemiology aspects.
Nevertheless, there is a lack of information In surgical procedure, extension of resection,
limphoadenectomy, surgical complications.
The same limited informations are evident in chemotherapy and radiotherapy schedules.
Please move the limitations of the study at the end of discussion paragraph.
The take home message in therapeutic approach in this field should be added in the conclusions.
assistant